Cited by 411

The DOI matches its Crossref record.

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study

Al-Chalabi, Ammar, Calvo, Andrea, Chio, Adriano, Colville, Shuna, Ellis, Cathy M, Hardiman, Orla, Heverin, Mark, Howard, Robin S, Huisman, Mark H B, Keren, Noa, Leigh, P Nigel, Mazzini, Letizia, Mora, Gabriele, Orrell, Richard W, Rooney, James, Scott, Kirsten M, Scotton, William J, Seelen, Meinie, Shaw, Christopher E, Sidle, Katie S, Swingler, Robert, Tsuda, Miho, Veldink, Jan H, Visser, Anne E, van den Berg, Leonard H, Pearce, Neil·2014·The Lancet Neurology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(14)70219-4

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 29

  1. Byrne, 2013, Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis, Ann Neurol, 74, 699, 10.1002/ana.23969 · DOI
  2. Al-Chalabi, 2011, Modelling the effects of penetrance and family size on rates of sporadic and familial disease, Hum Hered, 71, 281, 10.1159/000330167 · DOI
  3. Chio, 2009, Epidemiology of ALS in Italy: a 10-year prospective population-based study, Neurology, 72, 725, 10.1212/01.wnl.0000343008.26874.d1 · DOI
  4. Ravits, 2009, ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration, Neurology, 73, 805, 10.1212/WNL.0b013e3181b6bbbd · DOI
  5. Brown, 2005, Neurodegenerative diseases: An overview of environmental risk factors, Environ Health Perspect, 113, 1250, 10.1289/ehp.7567 · DOI
  6. Hornsby, 2007, What can we learn from the population incidence of cancer? Armitage and Doll revisited, Lancet Oncol, 8, 1030, 10.1016/S1470-2045(07)70343-1 · DOI
  7. Armitage, 1954, The age distribution of cancer and a multi-stage theory of carcinogenesis, Br J Cancer, 8, 1, 10.1038/bjc.1954.1 · DOI · Paper page
  8. Fisher, 1951, A hypothesis for the origin of cancer foci, Cancer, 4, 916, 10.1002/1097-0142(195109)4:5<916::AID-CNCR2820040504>3.0.CO;2-7 · DOI
  9. Nordling, 1953, A new theory on cancer-inducing mechanism, Br J Cancer, 7, 68, 10.1038/bjc.1953.8 · DOI
  10. Armitage, 1954, The age distribution of cancer and a multi-stage theory of carcinogenesis, Br J Cancer, 8, 1, 10.1038/bjc.1954.1 · DOI · Paper page
  11. Rooney, 2013, Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995–2010, PLoS One, 8, e74733, 10.1371/journal.pone.0074733 · DOI
  12. Huisman, 2013, Lifetime physical activity and the risk of amyotrophic lateral sclerosis, J Neurol Neurosurg Psychiatry, 84, 976, 10.1136/jnnp-2012-304724 · DOI · Paper page
  13. de Jong, 2012, Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study, Am J Epidemiol, 176, 233, 10.1093/aje/kws015 · DOI
  14. Chancellor, 1993, The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register, J Neurol, 240, 339, 10.1007/BF00839964 · DOI
  15. Abhinav, 2007, Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry), Neuroepidemiology, 29, 44, 10.1159/000108917 · DOI
  16. Forbes, 2007, The incidence of motor nueron disease in Scotland, J Neurol, 254, 866, 10.1007/s00415-006-0454-y · DOI
  17. Marrie, 2010, The rising prevalence and changing age distribution of multiple sclerosis in Manitoba, Neurology, 74, 465, 10.1212/WNL.0b013e3181cf6ec0 · DOI · Paper page
  18. Dorn, 1959, Morbidity from cancer in the United States, Public Health Monogr, 56, 1
  19. Frank, 2004, Age-specific acceleration of cancer, Curr Biol, 2014, 242, 10.1016/j.cub.2003.12.026 · DOI
  20. Wang, 2011, Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts, Arch Neurol, 68, 207, 10.1001/archneurol.2010.367 · DOI
  21. Andersen, 2011, Clinical genetics of amyotrophic lateral sclerosis: what do we really know?, Nat Rev Neurol, 7, 603, 10.1038/nrneurol.2011.150 · DOI · Paper page
  22. Al-Chalabi, 2013, The epidemiology of ALS: a conspiracy of genes, environment and time, Nat Rev Neurol, 9, 617, 10.1038/nrneurol.2013.203 · DOI
  23. Estrin, 1977, Amyotrophic lateral sclerosis in dizygotic twins, Neurology, 27, 692, 10.1212/WNL.27.7.692 · DOI
  24. Frank, 2010, Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration, Proc Natl Acad Sci USA, 107, 1725, 10.1073/pnas.0909343106 · DOI
  25. Polymenidou, 2011, The seeds of neurodegeneration: prion-like spreading in ALS, Cell, 147, 498, 10.1016/j.cell.2011.10.011 · DOI
  26. Plun-Favreau, 2010, Cancer and neurodegeneration: between the devil and the deep blue sea, PLoS Genet, 6, e1001257, 10.1371/journal.pgen.1001257 · DOI
  27. Andersen, 1997, Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia, Brain, 120, 1723, 10.1093/brain/120.10.1723 · DOI
  28. Cudkowicz, 1997, Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis, Ann Neurol, 41, 210, 10.1002/ana.410410212 · DOI
  29. Byrne, 2012, Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study, Lancet Neurol, 11, 232, 10.1016/S1474-4422(12)70014-5 · DOI

Cited by

Sorted by citations

Metadata

Authors
Al-Chalabi, A., Calvo, A., Chio, A., Colville, S., Ellis, C. M., Hardiman, O., Heverin, M., Howard, R. S., Huisman, M. H. B., Keren, N., Leigh, P. N., Mazzini, L., Mora, G., Orrell, R. W., Rooney, J., Scott, K. M., Scotton, W. J., Seelen, M., Shaw, C. E., Sidle, K. S., Swingler, R., Tsuda, M., Veldink, J. H., Visser, A. E., van den Berg, L. H., & Pearce, N.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2014-11
Volume
13
Issue
11
Pages
1108-1113
ISSN
1474-4422
Cited by
411
References
0
Language
en
Funders
  • King&apos;s College London
  • EU Joint Programme – Neurodegenerative Disease Research
  • Adessium Foundation
  • ZonMw
  • Medical Research Council
  • Stichting ALS Nederland
  • Ministero della Salute
  • Economic and Social Research Council
  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • National Institute for Health and Care Research
  • Prinses Beatrix Spierfonds (PB 0703)
  • Motor Neurone Disease Association
  • Seventh Framework Programme (259867)
  • Baxter International

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review